Sangamo Biosciences (SGMO) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. PLTR
4. SPY
5. KTOS
6. CSCO
7. ALHC
8. AON
9. TMUS
10. BMY

Go back to Sangamo Biosciences (SGMO) Tops Q1 EPS by 3c

Sangamo Therapeutics Reports First Quarter 2017 Financial Results

May 10, 2017 4:01 PM EDT

RICHMOND, Calif., May 10, 2017 /PRNewswire/ -- 

Company Also Separately Announced Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Gene Therapy Program

Conference Call and Webcast at 5:00 p.m. Eastern Time Today Will Discuss Structure and Terms of Collaboration with Pfizer

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its first quarter 2017 financial results and recent accomplishments.

Recent... More